XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.4
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Jan. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The Company's assets and liabilities that were measured at fair value on a recurring basis are set forth by level within the fair value hierarchy in the following tables (in thousands):
As of January 31, 2023
Quoted Prices
in Active Markets for Identical Assets
(Level 1)
Significant
Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Total
Assets:
Deferred compensation plan:
Corporate-owned life insurance$— $218,964 $— $218,964 
Money market fund15,317 — — 15,317 
Total assets$15,317 $218,964 $— $234,281 
Liabilities:
Contingent consideration $— $— $74,385 $74,385 
As of October 31, 2022
Quoted Prices
in Active Markets for Identical Assets (Level 1)
Significant
Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Total
Assets:
Deferred compensation plan:
Corporate-owned life insurance$— $201,239 $— $201,239 
Money market fund3,477 — — 3,477 
Total assets$3,477 $201,239 $— $204,716 
Liabilities:
Contingent consideration $— $— $82,803 $82,803 
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
The following unobservable inputs were used to derive the estimated fair value of the Company's Level 3 contingent consideration liabilities as of January 31, 2023 ($ in thousands):
Unobservable Weighted
Acquisition Date Fair Value Input Range
Average (1)
9-1-2022$6,112Compound annual revenue growth rate
0% - 17%
13%
Discount rate
7.9% - 7.9%
7.9%
7-18-202213,309Compound annual revenue growth rate
(1%) - 6%
3%
Discount rate
7.9% - 7.9%
7.9%
3-17-20229,494Compound annual revenue growth rate
(3%) - 7%
2%
Discount rate
6.9% - 6.9%
6.9%
8-4-202117,957Compound annual revenue growth rate
3% - 10%
8%
Discount rate
7.9% - 8.6%
8.1%
8-18-20208,280Compound annual revenue growth rate
15% - 24%
22%
Discount rate
8.6% - 8.6%
8.6%
9-15-201719,233Compound annual revenue growth rate
0% - 6%
5%
Discount rate
5.9% - 5.9%
5.9%
(1)    Unobservable inputs were weighted by the relative fair value of the contingent consideration liability.
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Changes in the Company’s contingent consideration liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3) for the three months ended January 31, 2023 are as follows (in thousands):
Liabilities
Balance as of October 31, 2022$82,803 
Payment of contingent consideration(10,009)
Increase in accrued contingent consideration, net1,336 
Foreign currency transaction adjustments255 
 $74,385 
Included in the accompanying Condensed Consolidated Balance Sheet
 under the following captions:
Accrued expenses and other current liabilities$19,233 
Other long-term liabilities55,152 
$74,385